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We investigated the involvement of GABAergic mechanisms of the central amygdaloid nucleus (CeA) in unanesthetized rats
subjected to acute isotonic or hypertonic blood volume expansion (BVE). Male Wistar rats bearing cannulas unilaterally
implanted in the CeA were treated with vehicle, muscimol (0.2 nmol/0.2 μL) or bicuculline (1.6 nmol/0.2 μL) in the CeA, followed
by isotonic or hypertonic BVE (0.15 or 0.3 M NaCl, 2 mL/100 g body weight over 1 min). The vehicle-treated group showed an
increase in sodium excretion, urinary volume, plasma oxytocin (OT), and atrial natriuretic peptide (ANP) levels compared to
control rats. Muscimol reduced the effects of BVE on sodium excretion (isotonic: 2.4 ± 0.3 vs vehicle: 4.8 ± 0.2 and hypertonic:
4.0 ± 0.7 vs vehicle: 8.7 ± 0.6 μEq·100 g-1·40 min-1); urinary volume after hypertonic BVE (83.8 ± 10 vs vehicle: 255.6 ± 16.5
μL·100 g-1·40 min-1); plasma OT levels (isotonic: 15.3 ± 0.6 vs vehicle: 19.3 ± 1 and hypertonic: 26.5 ± 2.6 vs vehicle: 48 ± 3 pg/
mL), and ANP levels (isotonic: 97 ± 12.8 vs vehicle: 258.3 ± 28.1 and hypertonic: 160 ± 14.6 vs vehicle: 318 ± 16.3 pg/mL).
Bicuculline reduced the effects of isotonic or hypertonic BVE on urinary volume and ANP levels compared to vehicle-treated rats.
However, bicuculline enhanced the effects of hypertonic BVE on plasma OT levels. These data suggest that CeA GABAergic
mechanisms are involved in the control of ANP and OT secretion, as well as in sodium and water excretion in response to isotonic
or hypertonic blood volume expansion.
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Introduction
Blood volume expansion (BVE) induces several regu-
latory responses by reflex mechanisms, including inhibi-
tion of sympathetic outflow to the kidney, heart, and blood
vessels, reduction of renin and vasopressin secretion, and
increased atrial natriuretic peptide (ANP) and oxytocin
(OT) release that leads to diuresis and natriuresis (1-3).
The central amygdaloid nucleus (CeA) is an important
constituent of central pathways that regulate cardiovascu-
lar control as well as hormonal and behavioral responses
in order to minimize and correct sodium deficits (4). In turn,
CeA projections to the hypothalamus and the brainstem
have been shown to be involved in blood pressure control
(5). Electrical and chemical stimulation of the CeA in anes-
thetized rats reduces arterial pressure and heart rate (4)
and also alters the development of spontaneous hyperten-
sion in rats (6). Lesions and chemical stimulation of the
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amygdaloid complex inhibit sodium intake (7). Rats with
lesions of the CeA also fail to ingest 0.5 M NaCl in response
to activation of the brain angiotensin or to systemic miner-
alocorticoid administration that produces a strong NaCl
appetite in controls (8). Zardetto-Smith et al. (9) demon-
strated that electrolyte lesions of the CeA and bed nucleus
of the stria terminalis (BNST) cause a significant reduction
in the sodium intake induced by systemic administration of
yohimbine (an α-2 adrenoceptor antagonist) or by sodium
depletion induced by furosemide.
Godino et al. (10) showed that volume-expanded rats
had a significant increase in Fos-ir neurons in the CeA and
the BNST. In addition, Margatho et al. (11) showed an
increase of Fos expression in retrogradely labeled cells of
the CeA and BNST, adding new information concerning
the specific groups of neurons involved in the body volume
regulation that have direct or monosynaptic connections
with the lateral parabrachial nucleus in response to iso-
tonic BVE.
GABA is a dominant inhibitory neurotransmitter in the
brain known to play an important role in the central sympa-
thetic and cardiovascular regulation. Intracerebroventricu-
lar (icv) injections of GABA agonists decrease arterial
blood pressure, heart rate, and sympathetic nerve activity,
while icv injections of GABA antagonists, such as bicucul-
line methiodide, markedly increase arterial blood pressure
and heart rate due to an increase in sympathetic nerve
activity (12). The CeA contains large populations of GABA-
ergic neurons and its ionotropic receptor GABAA is blocked
by low doses of bicuculline and is positively modulated by
benzodiazepines, anesthetics, and barbiturates (13).
Ciriello and Roder (14) reported that microinjections of
GABA or bicuculline significantly attenuated the magni-
tude of the depressor and bradycardic responses elicited
by selective activation of CeA neurons by L-glutamate (an
excitatory amino acid) in anesthetized rats.
A number of neuroendocrinological studies have indi-
cated a central GABAergic action in the control of anterior
pituitary hormone secretion (15). Moreover, GABAergic
nerve terminals have been observed in neurosecretory
nerve endings in the neurohypophysis (16), suggesting an
important role for the inhibitory neurotransmitter GABA in
regulating the activity of oxytocin neurons (17). In addition,
several limbic structures, including various parts of the
amygdaloid nuclei, have been shown to exert an inhibitory
influence on the electrical activity of supraoptic and para-
ventricular magnocellular neurosecretory cells recorded in
vivo (18).
However, the contribution of amygdala GABA systems
to the responses induced by BVE has not been demon-
strated. Thus, the aim of the present study was to deter-
mine the participation of the GABAergic system by the
administration of muscimol or bicuculline into the CeA in
the control of the sodium excretion, urinary volume, plas-
ma levels of OT and ANP in response to BVE.
Material and Methods
Animals
Male Wistar rats (280-350 g) from the Central Animal
Facility of the Ribeirão Preto Campus, University of São
Paulo, were housed in individual stainless steel cages in a
room with controlled temperature (23 ± 2°C) and a 12:12-
h light:dark cycle (light on at 7:00 am), with free access to
food pellets and tap water. The experiments were per-
formed between 9:00 am and 1:00 pm. All procedures for
care and use of animals were approved by the Committee
for Animal Use of the School of Medicine of Ribeirão Preto,
University of São Paulo (#009/2006).
CeA cannulation
Rats were anesthetized with 2,2,2-tribromoethanol (Al-
drich Chemical Co., USA; 200 mg/kg body weight) and
placed in a Kopf stereotaxic apparatus (model 900). The
skull was leveled between bregma and lambda. Stainless
steel guide cannulas (0.4 mm ID, 0.6 mm OD) were unilat-
erally implanted into the CeA using the following coordi-
nates: 2.2 mm caudal to the bregma, 4.5 mm lateral to the
midline and 7.2 mm below the dura mater. The tips of the
guide cannulas were targeted to be placed 2 mm above
each CeA. Cannulas were fixed to the cranium using
dental acrylic resin and two jeweller’s screws. A 30-gauge
metal wire filled the cannulas, except during the injections.
After surgery, the rats received a prophylactic injection of
penicillin (20,000 units, im) and were allowed to recover for
7 days, during which they were handled daily and habitu-
ated to the removal of the obturator of the guide cannula
and to the gavage procedures.
Histology of the CeA
After the experiments, animals received unilateral in-
jections of 2% Evans blue solution (0.2 μL/site) into the
CeA, were deeply anesthetized with sodium thiopental (80
mg/kg body weight) and perfused transcardially with iso-
tonic NaCl followed by 10% formalin. The brain was re-
moved, fixed in 10% formalin, frozen, cut in 50-μm coronal
sections, stained with Nissl (cresyl violet) and analyzed by
light microscopy (Axioskope 35M, Zeiss) to verify the injec-
tion site into the CeA.
Blood volume expansion
Twenty-four hours before the experiment, rats anesthe-
116
Braz J Med Biol Res 42(1) 2009
L.O. Margatho et al.
www.bjournal.com.br
tized with 2,2,2-tribromoethanol (200 mg/kg body weight)
had a catheter inserted into the right external jugular vein
and placed in the right atrium, as previously described (19).
On the day of the experiment, extracellular volume expan-
sion was performed in conscious, freely moving rats by an
intravenous injection of isotonic (0.15 M) or hypertonic (0.30
M) NaCl solution (2 mL/100 body weight) over 1 min.
Determination of sodium excretion and urinary volume
Urinary sodium concentration was determined by flame
photometry (Micronal Model b 262, Brazil). The rates of
urinary sodium excretion were calculated by multiplying
the urinary sodium concentration times the urinary volume
and expressed as μEq/100 g body weight. Urinary volume
was expressed as mL/100 g body weight.
Determination of plasma ANP and OT concentrations
Plasma levels of ANP and OT were measured by
radioimmunoassay as previously described (20,21). OT
was extracted from 1 mL of plasma with acetone and
petroleum ether, and ANP was extracted from 1 mL of
plasma using Sep-Pak C-18 cartridges (Waters Corpora-
tion, USA). The percentages of recovery after extraction
were 85 and 90% for OT and ANP, respectively. The assay
sensitivity and intra- and interassay coefficients of varia-
tion were 0.9 pg/mL, 7.0 and 12.6% for OT, and 7.0 pg/mL,
6.0 and 10% for ANP.
Drugs
Muscimol (Tocris, Cookson, USA) was dissolved in
isotonic saline and bicuculline (Research Biomedicals Inc.,
USA) was dissolved in a mix of propylene glycol/water
(2:1). The doses of muscimol and bicuculline used in the
present study were selected based on a previous study
(22). The CeA injections were performed using a 10-μL
Hamilton syringe connected by polyethylene tubing (PE-
10) to an injector needle (0.3 mm OD). The injector needle
was 2 mm longer than the guide cannula. Each rat re-
ceived only one CeA treatment.
Statistical analysis
Data are reported as means ± SEM. Renal and hormo-
nal responses were analyzed by two-way analysis of vari-
ance (ANOVA) followed by the post hoc Newman Keuls
test, using treatment (drugs) and time as factors. Statistical
analysis was performed using the Sigma Stat computer
program, with differences considered significant at P <
0.05.
Experimental protocol
Experiment 1. Effect of GABA agonist or antagonist
injection into the CeA on urinary sodium and water excre-
tion induced by BVE. Rats had access to water, but not
food, for 12 h before starting the experiment. After this
period, the animals were weighed and received one intra-
gastric water load (37°C, 5% body weight) in order to
maintain constant urine flow. The animals then received a
unilateral CeA injection of muscimol (0.2 nmol), bicuculline
(1.6 nmol) or isotonic saline in a volume of 0.2 μL. For
these injections, the rats were removed from their home
cages and the injection cannula was introduced into the
guide cannula. The injection took 60 s. The animals were
then placed in individual metabolic cages without access
to food or water. Twenty minutes after the CeA injections,
rats were subjected to isotonic or hypertonic extracellular
volume expansion. Two urine samples were collected at
20-min intervals, starting immediately after extracellular
volume expansion. Complete voiding of urine was manu-
ally induced by gently pressing the suprapubic region of
the animal at the end of each interval. The same CeA
treatments were performed in control animals that re-
ceived one water load without blood volume expansion.
Experiment 2. Effects of GABA agonist or antagonist
injection into the CeA on ANP and OT plasma levels
induced by BVE. In this experiment, isotonic or hypertonic
BVE was performed in animals injected unilaterally into the
CeA with vehicle, muscimol (0.2 nmol/0.2 μL) or bicucul-
line (1.6 nmol/0.2 μL) as described in Experiment 1. Five
minutes after BVE, unanesthetized rats were decapitated
and trunk blood was collected into chilled plastic tubes
containing heparin for OT determination, or EDTA (10 μg/
mL) and proteolytic enzyme inhibitors (20 μL 1 mM phenyl-
methylsulfonyl fluoride and 20 μL 500 μM pepstatin A) for
the determination of ANP. Blood samples were collected 5
min after BVE because peak hormone levels occur around
this time (23). The same CeA treatments were performed
in control animals without BVE.
Results
Histological analysis of the CeA
In Figure 1, plate A shows a photomicrograph of a
Nissl-stained section through the CeA and plate B shows
the correct cannula placement in the CeA reaching the
lateral, medial and capsular portions of the CeA, corre-
sponding to -2.56 mm from bregma according to the coor-
dinates described in the Paxinos and Watson Atlas (24).
Effect of GABA agonist or antagonist injection into the CeA
on urinary sodium and water excretion induced by BVE
In rats not subjected to isotonic or hypertonic BVE that
received muscimol, bicuculline or vehicle into the CeA,
117
Braz J Med Biol Res 42(1) 2009
GABAergic system and amygdaloid nucleus in volume expansion
www.bjournal.com.br
Figure 1. A, Photomicrograph of a representative Nissl-stained section through the central amygdaloid nucleus (CeA) corresponding
to -2.56 mm from the bregma according to the Atlas of Paxinos and Watson (24); B, Photomicrograph showing the injection site into
the CeA (arrow) at the same level as A. BLA = basolateral amygdaloid nucleus; Cpu = caudate putamen/striatum; ic = internal
capsule; LH = lateral hypothalamic area; MeA = medial amygdaloid nucleus; opt = optic tract. Bar: 3 mm.
Cpu
CeA
BLAMeA
ic
LH
opt
Cpu
CeA
BLAMeA
ic
LH
opt
two-way ANOVA showed no significant difference in main
effects between treatments for sodium excretion and uri-
nary volume (Figure 2A-D).
In rats pretreated with vehicle into the CeA, there was
an increase of sodium excretion (Figure 2A and B) and
urinary volume (Figure 2C and D) following isotonic BVE
(sodium excretion: 4.8 ± 0.2 μEq·100 g-1·40 min-1, N = 8 vs
control: 0.5 ± 0.2 μEq·100 g-1·40 min-1, N = 8; urinary
volume: 152 ± 10.5 μL·100 g-1·40 min-1, N = 8 vs control: 60
± 9.1 μL·100 g-1·40 min-1, N = 8) and hypertonic BVE
(sodium excretion: 8.7 ± 0.6 μEq·100 g-1·40 min-1, N = 8;
urinary volume: 255.6 ± 16.5 μL·100 g-1·40 min-1, N = 8).
Unilateral injections of muscimol into the CeA reduced
the increase in sodium excretion after isotonic (2.4 ± 0.3
μEq·100 g-1·40 min-1, N = 6) or hypertonic BVE (4.0 ± 0.7
μEq·100 g-1·40 min-1, N = 6) in comparison to vehicle-
treated group (Figure 2A and B). In addition, pretreatment
with muscimol into the CeA induced a decrease of urine
output after hypertonic BVE (83.8 ± 10 μL·100 g-1·40 min-1,
N = 6) and produced no changes in response to isotonic
BVE (Figure 2C and D). In rats pretreated with bicuculline
into the CeA, there was a decrease in urine output after
isotonic (98.8 ± 14.4 μL·100 g-1·40 min-1, N = 6) and
hypertonic BVE (154 ± 10 μL·100 g-1·40 min-1, N = 6)
compared to the vehicle-treated group (Figure 2C and D).
In regard to sodium excretion, bicuculline did not affect the
natriuresis induced by isotonic or hypertonic BVE.
Effect of GABA agonist or antagonist injection into the
CeA on plasma ANP and OT levels induced by BVE. In rats
not subjected to isotonic or hypertonic BVE that received
muscimol, bicuculline or vehicle into the CeA, two-way
ANOVA showed no significant main effects between treat-
ments for plasma ANP and OT levels (Figure 3A-D).
In rats pretreated with vehicle into the CeA, there was
an increase of plasma OT (Figure 3A and B) and ANP
(Figure 3C and D) concentrations following isotonic BVE
(OT: 19.3 ± 1 pg/mL, N = 8 vs control: 8.8 ± 1.2 pg/mL, N =
6); ANP: (258.3 ± 28.1 pg/mL, N = 8 vs control: 65.3 ± 14
pg/mL, N = 6) and hypertonic BVE (OT: 48 ± 3 pg/mL, N =
8; ANP: 318 ± 16.3 pg/mL, N = 8).
Unilateral CeA injections of muscimol induced a de-
crease of plasma OT levels in response to isotonic or
hypertonic BVE (15.3 ± 0.6 pg/mL, N = 8 and 26.5 ± 2.6 pg/
mL, N = 8, respectively; Figure 3A,B) compared to the
vehicle-treated group. In addition, plasma ANP concentra-
tion was also reduced in response to isotonic (97 ± 12.8 pg/
mL, N = 8; Figure 3C) and hypertonic BVE (160 ± 14.6 pg/
mL, N = 8; Figure 3D).
Bicuculline into the CeA decreased plasma ANP in rats
subjected to isotonic (167 ± 12 pg/mL, N = 8) or hypertonic
(209.7 ± 14.6 pg/mL, N = 8) BVE (Figure 3C and D). On the
other hand, bicuculline into the CeA increased the effects
of hypertonic blood volume expansion on plasma OT lev-
els (60 ± 2.6 pg/mL, N = 8; Figure 3B).
A B
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Figure 2. Sodium excretion
(A,B) and urinary volume (C,
D) in rats that received an
injection of vehicle (N = 8),
muscimol (0.2 nmol/0.2 μL,
N = 6-8) or bicuculline (1.6
nmol/0.2 μL, N = 6-7) into the
central amygdaloid nucleus
and were subjected or not to
isotonic or hypertonic blood
volume expansion (BVE).
Data are reported as means
± SEM. *P < 0.05 vs control
+ vehicle; +P < 0.05 vs BVE
+ vehicle (two-way ANOVA
followed by the post hoc
Newman Keuls test).
Figure 3. Plasma levels of
oxytocin (OT; A,B) and atrial
natriuretic peptide (ANP; C,
D) in rats that received an
injection of vehicle (N = 6-8),
muscimol (0.2 nmol/0.2 μL, N
= 6-8) or bicuculline (1.6
nmol/0.2 μL, N = 6-8) into the
central amygdaloid nucleus
and were subjected or not to
isotonic or hypertonic blood
volume expansion (BVE).
Data are reported as means
± SEM. *P < 0.05 vs control +
vehicle; +P < 0.05 vs BVE +
vehicle (two-way ANOVA fol-
lowed by the post hoc New-
man Keuls test).
Discussion
The present results show that sodium excretion, plas-
ma OT and ANP levels induced by isotonic or hypertonic
BVE were reduced in rats pretreated with the GABAergic
agonist muscimol in the CeA. Additionally, it was observed
that muscimol injection into the CeA significantly reduced
urine output in rats subjected to hypertonic BVE. Based on
the data obtained, we propose that the reduction of plasma
ANP and OT levels after injection of muscimol into the CeA
may contribute to the reduced sodium excretion after iso-
or hypertonic BVE. In spite of unilateral injection of musci-
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mol, bicuculline and vehicle into the CeA, the present data
show significant hormonal responses and urinary excre-
tion results in response to iso- or hypertonic BVE. Thus, it
is reasonable to consider that bilateral CeA treatment
probably would induce more pronounced effects.
It is well known that OT is synthesized within the
neurons of the supraoptic (SON) and paraventricular nu-
cleus (PVN) in the hypothalamus and is released into the
circulation from the nerve endings in the neurohypophysis.
Previous studies (3,25) have shown that the stimulation of
OT secretion could be induced by activation of intrahypo-
thalamic ANPergic terminals. These, in turn, would induce
the synthesis and central release of ANP that would acti-
vate the neurohypophysis release of OT. Once released
into the circulation, OT induces the cardiac release of ANP,
leading to diuresis, natriuresis and vasodilatation to re-
establish body fluid homeostasis. Natriuresis induced by
extracellular volume expansion is mediated by ANP and
OT release (2,3,26), both of them circulate to the kidney
and act on renal specific receptors to reduce the sodium
reabsorption by a nitric oxide-cGMP mechanism (3,27).
Our findings suggest that, in response to BVE, musci-
mol injected into the CeA inhibits synaptic inputs mediated
by perinuclear GABAergic interneurones located around
the PVN and SON. It is reasonable to assume that the
oxytocinergic magnocellular neurons in the PVN and SON
receive these local GABAergic inhibitory inputs, leading to
a decrease of plasma OT and ANP release and the conse-
quent sodium excretion in response to iso- or hypertonic
BVE.
Decavel and Van den Pol (17) suggested that GABA is
the most important inhibitory neurotransmitter in the mag-
nocellular system. However, relatively few studies have
shown that inhibitory amino acids (i.e., GABA) mediate all
fast synaptic transmission in the magnocellular neuroen-
docrine system (28). Saridaki et al. (29), using the neuro-
secretosome perfusion model in rats, showed an inhibitory
action of muscimol on oxytocin release from neurohypo-
physeal neurosecretory terminals that was reversed by
bicuculline, providing evidence for a direct effect on GABAA
receptors at the posterior pituitary neurosecretosome ter-
minals. Similarly, using a microdialysis study, Engelmann
et al. (30) showed a GABAergic selective inhibition of the
secretory and basal electrical activity of putative OT neu-
rons in the SON, while bicuculline stimulated the release of
OT within the SON and into the blood. Other investigators
(31) verified the possibility that the GABA system might
inhibit the release of oxytocin, by measuring milk-ejection
responses and urinary output following icv hypertonic sa-
line administration in lactating rats. It was shown that
oxytocin release, as well as the pressor response, were
blocked by icv injection of GABA and muscimol, which was
due to central sympathetic stimulation. The present data
agree with the notion that GABAergic circuits mediate
inhibitory inputs to magnocellular neurons in the PVN and
SON, and further expand the understanding of the partici-
pation of limbic structures within these circuits, as pro-
posed by Tasker and Dudek (32).
We have previously shown (11) the morphofunctional
interrelationship between the lateral parabrachial nucleus
cells and specific afferent forebrain neuronal groups of
cells (including CeA, BNST and PVN) that are activated
after an isotonic BVE. As a result of this activated pathway,
BVE increases the release of OT and ANP into the blood
(10). Thus, taking into account the previous and current
data, it can be hypothesized that the CeA pathways stimu-
late ANP and OT secretion in the PVN, since it has been
shown that these structures are reciprocally connected
(33,34) and the CeA GABAergic blockade reduces these
responses. In addition, the CeA is also reciprocally con-
nected with the lateral part of the BNST, both structures
being major components of the central extended amygda-
la complex (35). The BNST GABA-producing neurons (36)
project to the PVN (37) and receive projections from more
distal limbic structures as well as from brainstem A1 norad-
renergic neurons and peptidergic afferents from the hypo-
thalamus. Since the central extended amygdala complex
is reciprocally connected with the hypothalamus, an inte-
grative site of neuroendocrine and autonomic functions
(34), it is plausible to consider the existence of a CeA
GABAergic system that integrates a neural network in-
volved in fluid balance control.
In the present study, bicuculline injection into the CeA
specifically regulated urinary volume and did not affect
sodium excretion in response to iso- or hypertonic BVE.
Voisin et al. (38), using urethane-anesthetized rats, re-
ported that icv or bilateral microinfusions of both muscimol
and bicuculline into the SON inhibited the milk ejection
reflex, probably by inhibition of the electrical activity of
oxytocinergic neurons. In view of these results, it can be
suggested that bicuculline inhibitory modulation through
GABAA receptors may be either the same as that of musci-
mol or may arise from the disinhibition of local inhibitory
neurons innervating magnocellular oxytocinergic neurons
in the hypothalamus, while muscimol may inhibit PVN/
SON oxytocinergic neurons directly. Further studies will be
necessary to understand the complex mechanism involv-
ing the blockade of GABAA receptors in the pattern of the
acute stimulus of BVE.
Water and sodium excretion are affected by changes in
arterial blood pressure. In the absence of blood pressure
determination in the present study, we cannot assure the
120
Braz J Med Biol Res 42(1) 2009
L.O. Margatho et al.
www.bjournal.com.br
contribution or not of hemodynamic changes in water and
sodium excretion. However, Goren et al. (39) have demon-
strated that GABAA receptors located in the CeA do not
have and essential role in cardiovascular regulation. These
investigators showed that bicuculline injection into the
CeA produced a slight increase in blood pressure (3 min at
least, which returned to basal levels and did not change
heart rate). In addition, microinjections of GABA agonists
into the CeA of awake rats did not elicit cardiovascular
responses (40).
Taken together, the present results represent the first
evidence to suggest that the GABAergic system in the
central amygdaloid nucleus modulates the physiological
mechanisms involved in the control of urine electrolyte and
hormone release in rats submitted to changes in extracel-
lular volume and plasma osmolality. These results suggest
the involvement of a GABAergic CeA system in a neural
circuit that controls body fluid homeostasis in response to
isotonic and hypertonic BVE.
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